171 related articles for article (PubMed ID: 34014906)
1. Protein-Activated Kinase 3 (PAK3)-Related Intellectual Disability Associated with Combined Immunodeficiency: A Case Report.
Almutairi O; Almutairi HA; Al Rushood M
Am J Case Rep; 2021 May; 22():e930966. PubMed ID: 34014906
[TBL] [Abstract][Full Text] [Related]
2. A de novo mutation in the X-linked PAK3 gene is the underlying cause of intellectual disability and macrocephaly in monozygotic twins.
Hertecant J; Komara M; Nagi A; Al-Zaabi O; Fathallah W; Cui H; Yang Y; Eng CM; Al Sorkhy M; Ghattas MA; Al-Gazali L; Ali BR
Eur J Med Genet; 2017 Apr; 60(4):212-216. PubMed ID: 28126652
[TBL] [Abstract][Full Text] [Related]
3. Clinical and Molecular Aspects of the Neurodevelopmental Disorder Associated with PAK3 Perturbation.
Pascolini G; Gaudioso F; Passarelli C; Novelli A; Di Giosaffatte N; Majore S; Grammatico P
J Mol Neurosci; 2021 Dec; 71(12):2474-2481. PubMed ID: 34227036
[TBL] [Abstract][Full Text] [Related]
4. A novel
Iida A; Takano K; Takeshita E; Abe-Hatano C; Hirabayashi S; Inaba Y; Kosugi S; Kamatani Y; Momozawa Y; Kubo M; Nakagawa E; Inoue K; Goto YI
Cold Spring Harb Mol Case Stud; 2019 Dec; 5(6):. PubMed ID: 31444167
[TBL] [Abstract][Full Text] [Related]
5. PAK3 mutations responsible for severe intellectual disability and callosal agenesis inhibit cell migration.
Duarte K; Heide S; Poëa-Guyon S; Rousseau V; Depienne C; Rastetter A; Nava C; Attié-Bitach T; Razavi F; Martinovic J; Moutard ML; Cherfils J; Mignot C; Héron D; Barnier JV
Neurobiol Dis; 2020 Mar; 136():104709. PubMed ID: 31843706
[TBL] [Abstract][Full Text] [Related]
6. Novel PAK3 gene missense variant associated with two Chinese siblings with intellectual disability: a case report.
Qian Y; Wu B; Lu Y; Zhou W; Wang S; Wang H
BMC Med Genet; 2020 Feb; 21(1):31. PubMed ID: 32050918
[TBL] [Abstract][Full Text] [Related]
7. Alteration of synaptic network dynamics by the intellectual disability protein PAK3.
Dubos A; Combeau G; Bernardinelli Y; Barnier JV; Hartley O; Gaertner H; Boda B; Muller D
J Neurosci; 2012 Jan; 32(2):519-27. PubMed ID: 22238087
[TBL] [Abstract][Full Text] [Related]
8. A mutation in PAK3 with a dual molecular effect deregulates the RAS/MAPK pathway and drives an X-linked syndromic phenotype.
Magini P; Pippucci T; Tsai IC; Coppola S; Stellacci E; Bartoletti-Stella A; Turchetti D; Graziano C; Cenacchi G; Neri I; Cordelli DM; Marchiani V; Bergamaschi R; Gasparre G; Neri G; Mazzanti L; Patrizi A; Franzoni E; Romeo G; Bordo D; Tartaglia M; Katsanis N; Seri M
Hum Mol Genet; 2014 Jul; 23(13):3607-17. PubMed ID: 24556213
[TBL] [Abstract][Full Text] [Related]
9. The p21-activated kinase PAK3 forms heterodimers with PAK1 in brain implementing trans-regulation of PAK3 activity.
Combeau G; Kreis P; Domenichini F; Amar M; Fossier P; Rousseau V; Barnier JV
J Biol Chem; 2012 Aug; 287(36):30084-96. PubMed ID: 22815483
[TBL] [Abstract][Full Text] [Related]
10. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis.
Castillon C; Gonzalez L; Domenichini F; Guyon S; Da Silva K; Durand C; Lestaevel P; Vaillend C; Laroche S; Barnier JV; Poirier R
Hum Mol Genet; 2020 Jul; 29(12):1950-1968. PubMed ID: 31943058
[TBL] [Abstract][Full Text] [Related]
11. Improvement of Self-Injury With Dopamine and Serotonin Replacement Therapy in a Patient With a Hemizygous PAK3 Mutation: A New Therapeutic Strategy for Neuropsychiatric Features of an Intellectual Disability Syndrome.
Horvath GA; Tarailo-Graovac M; Bartel T; Race S; Van Allen MI; Blydt-Hansen I; Ross CJ; Wasserman WW; Connolly MB; van Karnebeek CDM
J Child Neurol; 2018 Jan; 33(1):106-113. PubMed ID: 29246092
[TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability.
Muthusamy B; Selvan LDN; Nguyen TT; Manoj J; Stawiski EW; Jaiswal BS; Wang W; Raja R; Ramprasad VL; Gupta R; Murugan S; Kadandale JS; Prasad TSK; Reddy K; Peterson A; Pandey A; Seshagiri S; Girimaji SC; Gowda H
OMICS; 2017 May; 21(5):295-303. PubMed ID: 28481730
[TBL] [Abstract][Full Text] [Related]
13. PAK3 related mental disability: further characterization of the phenotype.
Peippo M; Koivisto AM; Särkämö T; Sipponen M; von Koskull H; Ylisaukko-oja T; Rehnström K; Froyen G; Ignatius J; Järvelä I
Am J Med Genet A; 2007 Oct; 143A(20):2406-16. PubMed ID: 17853471
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of a child with X-linked intellectual disability due to a maternal de novo splicing variant of the PAK3 gene].
Wang C; Qiu X; Hu H; Jin B; Cheng Y; Zhao Y; Zhou C; Ma L; Zhang Y; Zheng F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jul; 40(7):865-870. PubMed ID: 37368392
[TBL] [Abstract][Full Text] [Related]
15. PAK3 mutation in nonsyndromic X-linked mental retardation.
Allen KM; Gleeson JG; Bagrodia S; Partington MW; MacMillan JC; Cerione RA; Mulley JC; Walsh CA
Nat Genet; 1998 Sep; 20(1):25-30. PubMed ID: 9731525
[TBL] [Abstract][Full Text] [Related]
16. Further delineation of the phenotype of PAK3-associated x-linked intellectual disability: Identification of a novel missense mutation and review of literature.
Nagy D; Farkas K; Armengol L; Segura M; Esi Zodanu GK; Csányi B; Zimmermann A; Vámos B; Széll M
Eur J Med Genet; 2020 Apr; 63(4):103800. PubMed ID: 31678216
[No Abstract] [Full Text] [Related]
17. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation.
Bienvenu T; des Portes V; McDonell N; Carrié A; Zemni R; Couvert P; Ropers HH; Moraine C; van Bokhoven H; Fryns JP; Allen K; Walsh CA; Boué J; Kahn A; Chelly J; Beldjord C
Am J Med Genet; 2000 Aug; 93(4):294-8. PubMed ID: 10946356
[TBL] [Abstract][Full Text] [Related]
18. The p21-activated kinase 3 implicated in mental retardation regulates spine morphogenesis through a Cdc42-dependent pathway.
Kreis P; Thévenot E; Rousseau V; Boda B; Muller D; Barnier JV
J Biol Chem; 2007 Jul; 282(29):21497-506. PubMed ID: 17537723
[TBL] [Abstract][Full Text] [Related]
19. [Research progress on nonsyndromic X-linked mental retardation related gene PAK3].
Gao XC; Xi GS; Zhang FC
Yi Chuan; 2007 May; 29(5):523-7. PubMed ID: 17548318
[TBL] [Abstract][Full Text] [Related]
20. The intellectual disability protein PAK3 regulates oligodendrocyte precursor cell differentiation.
Maglorius Renkilaraj MRL; Baudouin L; Wells CM; Doulazmi M; Wehrlé R; Cannaya V; Bachelin C; Barnier JV; Jia Z; Nait Oumesmar B; Dusart I; Bouslama-Oueghlani L
Neurobiol Dis; 2017 Feb; 98():137-148. PubMed ID: 27940202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
